GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cizzle Biotechnology Holdings CIZ.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1.15p

0.00%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Cizzle Biotechnology Holdings — daily CIZ

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Cizzle Biotechnology Holdings on TradingView ↗
Market value
£4.6m
Last close × shares
Volume
2m
Shares, 9 Nov 2026

About Cizzle Biotechnology Holdings

Its shares trade on LSE under the ticker CIZ.L. It has been listed since 23 May 2007. In the fiscal year to 31 December 2018, it reported revenue of £74,000 and a net loss of £2.1m. At that date it held total assets of £96,000 and shareholders' equity of −£235,000.

Cizzle Biotechnology Holdings Plc is a holding company, which engages in detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. The Company’s proof-of-concept prototype test is based on the ability to detect a plasma biomarker, a variant of CIZ1 known as CIZ1B. CIZ1 is a cell nuclear protein involved in deoxyribonucleic acid (DNA) replication, and the targeted CIZ1B variant is correlated with early-stage lung cancer. The company helps to reduce the need for repeated computed tomography (CT) scanning. The firm provides its product AZD1656 is treatment for COVID19 patients. AZD1656 is an immunomodulator which damps down the inflammatory response characteristic of coronavirus disease (COVID-19) infection, while enhancing the part of the immune response. The firm has developed a prototype confirmative test to address the false positive rates of CT scanning to avoid unnecessary invasive testing.

Figures and description from our data supplier, not checked against the company's own report.

More about Cizzle Biotechnology Holdings →

Latest on Cizzle Biotechnology Holdings

Our reporting

We have not reported on Cizzle Biotechnology Holdings yet.

Next results

5 May 2027

Due on 5 May 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Cizzle Biotechnology Holdings's ticker?

Cizzle Biotechnology Holdings trades as CIZ.L on LSE, under ISIN GB00BNG2VN02.

What was Cizzle Biotechnology Holdings's last closing price?

1.15p on 9 Nov 2026. The figure is in GBp and is never converted.

When does Cizzle Biotechnology Holdings next report results?

Results are expected on 5 May 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.